Unified Research Ecosystem
A single, auditable computational framework supporting both subject-level characterization and cohort-scale discovery without algorithmic divergence.
Computational Architecture
Every analysis tool in the ecosystem derives from the same formalized methodology, described in a peer-reviewed publication (Menéndez-González, Alzheimer's & Dementia 2025), guaranteeing reproducible outcomes regardless of dataset scale.
Subject Analyzer
Standardized five-step ingestion pipeline for structuring genetic variants, fluid biomarkers, and volumetric imaging in individual research subjects.
Data Lab
Cohort-level statistical environment evaluating mechanistic hypothesis concordance across multi-omics datasets and imaging volumetry.
Batch Pipeline
High-throughput asynchronous processing for biobank-scale repositories with deterministic computation logs and checksum validation.
Causal validation (5/8 markers) and spatial concordance (12/32 regions) match independent reference Python and R execution outputs (preprint, unpublished manuscript, not peer-reviewed).
Architectural Comparison
Addressing the reproducibility crisis caused by ad-hoc, siloed statistical scripts.
| Dimension | Fragmented Analysis Pipelines | Neurodiagnoses Unified Architecture |
|---|---|---|
| Algorithmic Parity | Different mathematical implementations per tool | Identical core library for single cases and cohorts |
| Data Normalization | Inconsistent thresholds between research centers | Ontology-grounded three-axis reference bounds |
| Traceability & Logs | Scattered notebooks without execution hash | Deterministic provenance logs for every computation |
| Theoretical Foundation | Heuristic rules without published models | Framework described in a peer-reviewed publication (Alzheimer's & Dementia) |
Automated Statistical Services
Standardized analytical procedures available via deterministic API endpoints for cohort exploration.
Active Risk Modeling (Survival Analysis)
Evaluates whether integrating causal biomarker validation (Axis 1 → Axis 2) with Polygenic Risk Scores (PRS) provides incremental hazard ratio discrimination over static genetic models alone.
Multi-Axis Concordance Scoring
Determines whether high genetic risk manifests in expected fluid biomarker alterations and matches anatomical atrophy patterns in specified brain regions of interest.